Another update which rehashes old information and no real information on what activities are in place to prepare for phase 2 trials which are supposedly due to commence sometime next year (beginning, mid-year or end of year?????)
Will be another long wait before we hear new information and still no idea on what the intentions of Life Biosciences will be with ATH. Hopefully no capital raising to further dilute what is already a penny stock.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $128.9M | |||
| Open | High | Low | Value | Volume |
| 1.4¢ | 1.4¢ | 1.3¢ | $188.8K | 13.50M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 35 | 20724621 | 1.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.4¢ | 1182673 | 6 |
View Market Depth
| Last trade - 16.10pm 31/07/2025 (20 minute delay) ? |
| ATH (ASX) Chart |